These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2095154)

  • 1. Gastrointestinal activities of a new pirenzepine-analog, nuvenzepine, in the cat.
    Barocelli E; Chiavarini M; Gentile A; Lavezzo A; Impicciatore M
    Farmaco; 1990 Oct; 45(10):1089-99. PubMed ID: 2095154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of pirenzepine and cimetidine inhibition of centrally-mediated gastric acid and pepsin secretion in the gastric-fistula cat.
    Browning JG; Heathcote BV
    Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):288-96. PubMed ID: 6411019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional comparison between nuvenzepine and pirenzepine on different guinea pig isolated smooth muscle preparations.
    Barocelli E; Ballabeni V; Chiavarini M; Molina E; Impicciatore M
    Pharmacol Res; 1994; 30(2):161-70. PubMed ID: 7816744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric antisecretory activity of telenzepine, a new M1-selective muscarinic antagonist: comparison with pirenzepine.
    Coruzzi G; Adami M; Bertaccini G
    Arch Int Pharmacodyn Ther; 1989; 302():232-41. PubMed ID: 2636819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of intravenous pirenzepine on gastric acid and pepsin in man.
    el-Sabbagh HN; Prinz RA; Welbourn RB; Baron JH
    Scand J Gastroenterol Suppl; 1980; 66():73-7. PubMed ID: 6787694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-ulcer and secretion-inhibitory properties of the tricyclic derivative doxepin in rats and dogs.
    Leitold M; Fleissig W; Merk A
    Arzneimittelforschung; 1984; 34(4):468-73. PubMed ID: 6547610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pirenzepine on meal-stimulated acid secretion and gastrin release in normal man.
    Mignon M; Vatier J; Bauer P; Bonfils S
    Scand J Gastroenterol Suppl; 1982; 72():145-51. PubMed ID: 6753112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of various secretory inhibitors on peptic activity.
    Gabryelewicz A; Laszewicz W; Sarosiek J
    Scand J Gastroenterol Suppl; 1980; 66():79-85. PubMed ID: 6264587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional differences in motor responsiveness to antimuscarinic drugs in rabbit isolated small and large intestine.
    Barocelli E; Ballabeni V; Chiavarini M; Caretta A; Molina E; Impicciatore M
    Pharmacol Res; 1995 Jan; 31(1):43-8. PubMed ID: 7784305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of vagal stimulated acid secretion by pirenzepine and cimetidine.
    Scholten T; Fritsch WP; Müller JE; Hengels KJ
    Scand J Gastroenterol Suppl; 1982; 72():169-71. PubMed ID: 6957986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telenzepine, a new M1-receptor antagonist, is a more potent inhibitor of pentagastrin-stimulated gastric acid output than pirenzepine in dogs.
    Holtmann G; Küppers U; Singer MV
    Scand J Gastroenterol; 1990 Mar; 25(3):293-7. PubMed ID: 2320949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of atropine, pirenzepine and cimetidine on nocturnal gastro-intestinal motility and gastric acid secretion.
    Lederer PC; Thiemann R; Femppel J; Domschke W; Lux G
    Scand J Gastroenterol Suppl; 1982; 72():131-7. PubMed ID: 6957981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cimetidine and pirenzepine on peroperative electrical vagal stimulation of gastric acid secretion.
    Fritsch WP; Schacht U; Scholten T; Hengels KJ; Mueller J; Strasser K
    Scand J Gastroenterol Suppl; 1980; 66():95-100. PubMed ID: 6941381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of two doses of pirenzepine on histamine-stimulated gastric acid secretion in man.
    Eugenides N; Stockbrügger RW; Hobsley M; Cotton PB
    Scand J Gastroenterol Suppl; 1982; 72():125-9. PubMed ID: 6957980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pirenzepine and atropine on vagal and cholinergic gastric secretion and gastrin release and on heart rate in the dog.
    Hirschowitz BI; Fong J; Molina E
    J Pharmacol Exp Ther; 1983 May; 225(2):263-8. PubMed ID: 6132990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticholinergic action of pirenzepine (Gastrozepin) on isolated gastrointestinal tract smooth muscles.
    Ojewole JA
    Methods Find Exp Clin Pharmacol; 1983; 5(3):171-5. PubMed ID: 6688455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of "selective" antimuscarinic agents on gastric acid secretion and motility.
    Subissi A; Guelfi M; Maggi CA; Meli A
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):313-9. PubMed ID: 3161479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pirenzepine inhibits acid and pepsinogen secretion by the isolated perfused mouse stomach.
    Müller-Lissner SA; Szelenyi I; Engler H; Blum AL
    Scand J Gastroenterol Suppl; 1982; 72():101-3. PubMed ID: 6127794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a 100 mg pirenzepine--treatment on acid secretion and serum gastrin.
    Fritsch WP; Scholten T; Müller J; Hengels KJ; Hanrath KD
    Scand J Gastroenterol Suppl; 1982; 72():173-7. PubMed ID: 6957987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.
    Carmine AA; Brogden RN
    Drugs; 1985 Aug; 30(2):85-126. PubMed ID: 3928324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.